The utility of 1.5 tesla MR-guided adaptive stereotactic body radiotherapy for recurrent ovarian tumor – Case reports and review of the literature
Authors:
Open Access
- 22 September 2022
- journal article
- review article
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 99, 107696
Abstract
Although epithelioid ovarian cancer (EOC) is a radiosensitive tumor and radiotherapy (RT) played a significant role in adjuvant treatment management in the past, the role of RT has evolved with the advent of platinum-based chemotherapy regimens. Nonetheless, modern RT techniques may be useful in certain patients particularly those with recurrent disease. After surgery and chemotherapy, two patients, aged 57 and 70, presented with recurrent lesions in the parailiac region. The recurrent lesions were treated with high field 1.5-Tesla MR-Linac treatment in 5 fractions at a dose of 30 Gy. The patients tolerated the treatment well and were disease free after 12 and 20 months of magnetic resonance guided radiotherapy (MRgRT), respectively. MRgRT is a novel and rapidly evolving technology that allows for the highly precise treatment of even mobile targets through direct visualization of the tumor. The majority of patients with EOC frequently present with abdominal-pelvic recurrences. It has been demonstrated that EOC requires high radiation doses for curative treatment. MR-Linac enables monitoring of organ motion during treatment, which is necessary for delivering higher doses to target volumes while sparing surrounding organs. To reduce radiation doses to nearby normal tissues, MRgRT allows for the delivery of hypofractionated RT with tight safety margins. Regardless of initial resistance or gradual development of intolerance to standard chemotherapy regimens, the role of RT in patients with persistent or recurrent EOC should be reconsidered.Keywords
This publication has 12 references indexed in Scilit:
- The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) GuidelinesInternational Journal of Surgery, 2020
- Radiotherapy in women with epithelial ovarian cancer: historical role, current advances, and indicationsChinese Clinical Oncology, 2020
- Stereotactic body radiation therapy in the treatment of ovarian cancerRadiation Oncology, 2020
- Online MR-guided radiotherapy – A new era in radiotherapyClinical and Translational Radiation Oncology, 2019
- The role of radiotherapy in epithelial ovarian cancer: a literature overviewMedical Oncology, 2019
- MR-guidance in clinical reality: current treatment challenges and future perspectivesRadiation Oncology, 2019
- Salvage radiation therapy for localized recurrent ovarian cancerInternational Journal of Gynecological Cancer, 2019
- Long-term Benefit of Tumor Volume-DirectedInternational Journal of Gynecological Cancer, 2016
- Involved-field radiation therapy for locoregionally recurrent ovarian cancerGynecologic Oncology, 2013
- Risk stratification of abdominopelvic failure for FIGO stage III epithelial ovarian cancer patients: implications for adjuvant radiotherapyJournal of Gynecologic Oncology, 2013